<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed the medical records of 884 type 2 DM patients who were taking different antiplatelet agents for more than 2 years </plain></SENT>
<SENT sid="1" pm="."><plain>Based on the records, occurrences of cardiovascular events for 10 years were evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>The composite disease-free survival rate for cilostazol monotherapy group was similar to aspirin subgroup (p=0.133) </plain></SENT>
</text></document>